18 results on '"Reed, Eddie"'
Search Results
2. Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.
3. Abstract 771: Changes in the subcellular pharmacology of cisplatin, in response to treatment of cells with an anti-Gli1 shRNA
4. Abstract 3991: Protein phosphatase 2A (PP2A) downregulation is associated with androgen-independent and aggressive phenotypes in prostate cancer
5. Abstract 605: Olive polyphenol, hydroxytyrosol, exerts anti-tumor effects in prostate cancer cells by targeting Akt, STAT3 and AR signaling
6. Abstract 5613: A specific isoform of Gli1 binds the Gli-binding site of the c-jun and c-fos promoters
7. Abstract 834: Inhibition of Gli1 results in altered c-jun activation, inhibition of cisplatin-induced up-regulation of ERCC1, XPD, and XRCC1, and inhibition of platinum-DNA adduct repair
8. Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications
9. Abstract 3406: Understanding molecular pathway differences between ovarian cancer stem cells (OCSC) and non-ovarian cancer stem cells (non-OCSC) leads to the Hedgehog pathway as a common thread
10. Abstract 249: Inhibition of protein phosphatase 2A supports androgen-independent growth of prostate cancer cells
11. DNA Damage and Repair in Translational Oncology: An Overview
12. Abstract LB-281: Inhibition of Hedgehog results in altered regulation of c-jun and of ERCC1 in cisplatin-resistant A2780-CP70 human ovarian cancer cells
13. Abstract CN4-3: Factors that influence the regulation of ERCC1 in drug-resistant cells
14. Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1
15. A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane Chemotherapy
16. Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
17. ERCC1 and Clinical Resistance to Platinum-Based Therapy
18. Detection of Cyclin B1 Expression in G1-Phase Cancer Cell Lines and Cancer Tissues by Postsorting Western Blot Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.